Literature DB >> 15934435

Polymorphisms of the renin-angiotensin system genes in Brazilian patients with lupus nephropathy.

S R S Sprovieri1, Y A S Sens.   

Abstract

Genetic polymorphisms of the renin-angiotensin system (RAS) has been associated with cardiovascular events and the progression of nephropathy in several diseases. The objective of this study was to evaluate a possible association of the genetic polymorphisms of RAS with the development and/or progression of lupus nephritis in a Brazilian population. Seventy-five SLE patients with lupus nephropathy (LN group) were compared to 72 SLE patients without LN (SLE group) and 65 healthy individuals (CONTROL group), of sex and ethnic matched, in a Brazilian population sample. Mean global follow-up was 9 +/- 6 years for lupus without nephropathy and 11 +/- 7 years for lupus nephropathy. Following the extraction of genomic DNA from the leukocytes in the peripheral blood, angiotensin converting enzyme (ACE I/D), angiotensinogen (AGT M(235)T) and angiotensin II type 1 receptor (AGTR1 A(1166)C) genotypes were determined by the polymerase chain reaction. No significant difference of ACE, AGT and AGTR1 genotypes distribution between groups was observed in this study. There was no significant association between the variables of the RAS genotypes and the presence of hypertension in SLE. However, an increased frequency ofDD genotype (ACE I/D) was observed in SLE patients with LN who progressed to CRF compared to healthy controls (DD 60%, DI 26.7%, II 13.3% versus 27.7%, 60% and 12.3%, respectively; chi2 = 6.299, P = 0.0429). In the population studied, there was no influence of the RAS genetic polymorphisms in the development of lupus nephropathy, but the progression to CRF was associated with ACE DD polymorphism.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15934435     DOI: 10.1191/0961203305lu2093oa

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  7 in total

1.  Association study of ACE polymorphisms and systemic lupus erythematosus in Northern Chinese Han population.

Authors:  Ai-Min Gong; Xin-Yuan Li; Yi-Qin Wang; Hai-Xia Yan; Zhao-Xia Xu; Zhao Feng; Yi-Qiang Xie; De-Hui Yin; Shi-Zhong Yang
Journal:  Mol Biol Rep       Date:  2012-06-23       Impact factor: 2.316

2.  Angiotensin II type 1 receptor gene polymorphism and serum angiotensin-converting enzyme level in Egyptian children with systemic lupus erythematosus.

Authors:  Rasha Mohamed Saleh Shoaib; Ayman Hammad; Sohier Yahia; Afaf Elsaid; Camelia Adly Abdel-Malak
Journal:  Clin Rheumatol       Date:  2018-08-09       Impact factor: 2.980

3.  Blood pressure and renal hemodynamic responses to acute angiotensin II infusion are enhanced in a female mouse model of systemic lupus erythematosus.

Authors:  Marcia Venegas-Pont; Keisa W Mathis; Radu Iliescu; William H Ray; Porter H Glover; Michael J Ryan
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-09-07       Impact factor: 3.619

4.  Association of the G-463A myeloperoxidase gene polymorphism with renal disease in African Americans with systemic lupus erythematosus.

Authors:  Henda Bouali; Paul Nietert; Tamara M Nowling; Janardan Pandey; Mary Anne Dooley; Glinda Cooper; John Harley; Diane L Kamen; Jim Oates; Gary Gilkeson
Journal:  J Rheumatol       Date:  2007-09-15       Impact factor: 4.666

5.  Angiotensin-converting enzyme (ACE) gene insertion/deletion polymorphism is not a risk factor for hypertension in SLE nephritis.

Authors:  Vir S Negi; Panneer Devaraju; Reena Gulati
Journal:  Clin Rheumatol       Date:  2015-05-10       Impact factor: 2.980

6.  Association of the genetic polymorphisms of the ACE gene and the eNOS gene with lupus nephropathy in northern Chinese population.

Authors:  X Li; J An; R Guo; Z Jin; Y Li; Y Zhao; F Lu; H Lian; P Liu; Y Zhao; X Jin
Journal:  BMC Med Genet       Date:  2010-06-14       Impact factor: 2.103

7.  Frequency of APOE, MTHFR and ACE polymorphisms in the Zambian population.

Authors:  Masharip Atadzhanov; Mwila H Mwaba; Patrice N Mukomena; Shabir Lakhi; Peter Mwaba; Sruti Rayaprolu; James F Meschia; Owen A Ross
Journal:  BMC Res Notes       Date:  2014-03-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.